US Patent Issued to ChromaDex on Feb. 24 for "Nicotinamide riboside and derivatives thereof in intravenous formulations and methods of use thereof" (Colorado, Maryland Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,558,367, issued on Feb. 24, was assigned to ChromaDex Inc. (Los Angeles).

"Nicotinamide riboside and derivatives thereof in intravenous formulations and methods of use thereof" was invented by Aron Erickson (Berthoud, Colo.), Philip Redpath (Firestone, Colo.), Yasmeen Maisha Nkrumah-Elie (Denver) and Andrew Earl Shao (Monrovia, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A stable intravenous (I.V.) composition includes nicotinamide riboside (NR) as described, or other nicotinyl riboside compounds which are NAD+ precursors, in said intravenous form. NR chloride may be provided in an intravenous (I.V.) formulation for administration to a human subj...